Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

Por Furst, Daniel E., Emery, Paul
Publicado em 2014

Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to...

Por Woodworth, Thasia G, Furst, Daniel E
Publicado no Arthritis Res Ther (2014)

Description of the Efficacy and Safety of Three New Biologics in the Treatment of Rheumatoid Arthritis

Por Storage, Steven S., Agrawal, Harsh, Furst, Daniel E.
Publicado em 2010

Salicylate Metabolism in Twins: EVIDENCE SUGGESTING A GENETIC INFLUENCE AND INDUCTION OF SALICYLURATE FORMATION

Por Furst, Daniel E., Gupta, Niroo, Paulus, Harold E.
Publicado em 1977

The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation

Por Townes, Shatara V, Furst, Daniel E, Thenkondar, Anuradha
Publicado no Open Access Rheumatol (2012)

Biosimilars and the extrapolation of indications for inflammatory conditions

Por Tesser, John RP, Furst, Daniel E, Jacobs, Ira
Publicado no Biologics (2017)

Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement

Por Sullivan, Keith M., Shah, Ankoor, Sarantopoulos, Stefanie, Furst, Daniel E.
Publicado no Arthritis Rheumatol (2016)

Clinical trials in systemic sclerosis: lessons learned and outcomes

Por Matucci-Cerinic, Marco, Steen, Virginia D, Furst, Daniel E, Seibold, James R
Publicado em 2007

An International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outcome...

Por Hudson, Marie, Baron, Murray, Lo, Ernest, Weinfeld, Joanna, Furst, Daniel E., Khanna, Dinesh
Publicado em 2010

Work Productivity in Scleroderma – Analysis from the UCLA Scleroderma Quality of Life Study

Por Singh, Manjit K., Clements, Philip J., Furst, Daniel E., Maranian, Paul, Khanna, Dinesh
Publicado em 2012

Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

Por Nurmohamed, Michael, Bao, Yanjun, Signorovitch, James, Trahey, Alex, Mulani, Parvez, Furst, Daniel E
Publicado no RMD Open (2015)

The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis

Por Czirják, László, Nagy, Zoltán, Aringer, Martin, Riemekasten, Gabriela, Matucci‐Cerinic, Marco, Furst, Daniel E
Publicado em 2007

GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC

Por Fekete, Natalie, Rojewski, Markus T., Fürst, Daniel, Kreja, Ludwika, Ignatius, Anita, Dausend, Julia, Schrezenmeier, Hubert
Publicado em 2012

Wide-field imaging of birefringent synovial fluid crystals using lens-free polarized microscopy for gout diagnosis

Por Zhang, Yibo, Lee, Seung Yoon Celine, Zhang, Yun, Furst, Daniel, Fitzgerald, John, Ozcan, Aydogan
Publicado no Sci Rep (2016)

Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial

Por Khanna, Puja P., Furst, Daniel E., Clements, Philip J., Maranian, Paul, Indulkar, Lilavati, Khanna, Dinesh
Publicado em 2010

Prevalence and correlates of sleep disturbance in systemic sclerosis—results from the UCLA scleroderma quality of life study

Por Frech, Tracy, Hays, Ron D., Maranian, Paul, Clements, Philip J., Furst, Daniel E., Khanna, Dinesh
Publicado em 2011

Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design

Por Khanna, Dinesh, Seibold, James R., Wells, Athol, Distler, Oliver, Allanore, Yannick, Denton, Chris, Furst, Daniel E.
Publicado em 2010

Microchimerism of maternal origin persists into adult life

Por Maloney, Sean, Smith, Anajane, Furst, Daniel E., Myerson, David, Rupert, Kate, Evans, Paul C., Nelson, J. Lee
Publicado em 1999

Agreements and Discrepancies between FDA Reports and Journal Papers on Biologic Agents Approved for Rheumatoid Arthritis: A Meta-Research Project

Por Amarilyo, Gil, Furst, Daniel E., Woo, Jennifer M. P., Li, Wen, Bliddal, Henning, Christensen, Robin, Tarp, Simon
Publicado no PLoS One (2016)

Association between Initial Oral Therapy and Outcomes in Systemic Sclerosis-related Pulmonary Arterial Hypertension: Observations from PHAROS

Por Lammi, Matthew R., Mathai, Stephen C., Saketkoo, Lesley Ann, Domsic, Robyn T., Bojanowski, Christine, Furst, Daniel, Steen, Virginia
Publicado no Arthritis Rheumatol (2016)